Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Prestige Consumer Healthcare (PBH) over the last 16 years, with Q4 2025 value amounting to $7.6 million.

  • Prestige Consumer Healthcare's Depreciation & Amortization (CF) rose 1054.16% to $7.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.2 million, marking a year-over-year decrease of 192.11%. This contributed to the annual value of $30.2 million for FY2025, which is 163.65% down from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Depreciation & Amortization (CF) is $7.6 million, which was up 1054.16% from $7.7 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Depreciation & Amortization (CF) registered a high of $8.5 million during Q1 2022, and its lowest value of $6.9 million during Q4 2024.
  • For the 5-year period, Prestige Consumer Healthcare's Depreciation & Amortization (CF) averaged around $7.8 million, with its median value being $7.8 million (2024).
  • Per our database at Business Quant, Prestige Consumer Healthcare's Depreciation & Amortization (CF) surged by 1257.79% in 2022 and then tumbled by 1017.53% in 2024.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Depreciation & Amortization (CF) stood at $8.0 million in 2021, then rose by 0.99% to $8.1 million in 2022, then decreased by 5.95% to $7.6 million in 2023, then decreased by 10.18% to $6.9 million in 2024, then rose by 10.54% to $7.6 million in 2025.
  • Its last three reported values are $7.6 million in Q4 2025, $7.7 million for Q3 2025, and $7.7 million during Q2 2025.